Fulgent Genetics, Inc. (FLGT): Price and Financial Metrics


Fulgent Genetics, Inc. (FLGT)

Today's Latest Price: $32.53 USD

1.66 (-4.86%)

Updated Oct 30 4:00pm

Add FLGT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

FLGT Stock Summary

  • FLGT's current price/earnings ratio is 294.98, which is higher than 97.65% of US stocks with positive earnings.
  • The price/operating cash flow metric for Fulgent Genetics Inc is higher than 99.66% of stocks in our set with a positive cash flow.
  • The volatility of Fulgent Genetics Inc's share price is greater than that of 93.04% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Fulgent Genetics Inc are QLYS, NBIX, NVCR, SY, and SSTI.
  • Visit FLGT's SEC page to see the company's official filings. To visit the company's web site, go to www.fulgentgenetics.com.

FLGT Stock Price Chart Interactive Chart >

Price chart for FLGT

FLGT Price/Volume Stats

Current price $32.53 52-week high $52.47
Prev. close $34.19 52-week low $6.70
Day low $31.46 Volume 645,300
Day high $34.42 Avg. volume 581,903
50-day MA $36.79 Dividend yield N/A
200-day MA $22.69 Market Cap 719.40M

Fulgent Genetics, Inc. (FLGT) Company Bio


Fulgent Genetics, Inc., a technology company, focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is based in Temple City, California.


FLGT Latest News Stream


Event/Time News Detail
Loading, please wait...

FLGT Latest Social Stream


Loading social stream, please wait...

View Full FLGT Social Stream

Latest FLGT News From Around the Web

Below are the latest news stories about Fulgent Genetics Inc that investors may wish to consider to help them evaluate FLGT as an investment opportunity.

Fulgent Genetics +9.1% on move into SmallCap 600

Fulgent Genetics (FLGT) has jumped 9.1% postmarket on news that it's joining the S&P SmallCap 600 index. It's replacing Garrett Motion (GTX), which is filing for bankruptcy and has to leave the index. The move is effective prior to the open of trading on Friday, Sept. 25....

Seeking Alpha | September 21, 2020

Cramer Advises Viewers On Peloton, Vale And More

On CNBC's "Mad Money Lightning Round," Jim Cramer said NextEra Energy Inc (NYSE: NEE ) is the fastest-growing growth utility. If you want a growth utility that is the one. Cramer likes Peloton Interactive Inc (NASDAQ: PTON ), but it has runway up too high. He thinks it could trade even higher, but he doesn't like the risk-reward. Fulgent Genetics Inc (NASDAQ: FLGT ) … Full story available on Benzinga.com

Benzinga | September 18, 2020

Fulgent Genetics, NYC Health and Hospitals partner on back-to-school COVID-19 testing

Fulgent Genetics (FLGT) and New York City Health and Hospitals will provide COVID-19 testing to hundreds of thousands of students across approx. 1600 locations as they return to school in September and over the next several months.The Company will provide its FDA EUA-approved at-home test, Picture Genetics, a RT-PCR test that provides results...

Seeking Alpha | September 3, 2020

Fulgent Shares Up 10% On COVID-19 Testing Deal For New York Schools

Fulgent Genetics (NASDAQ: FLGT ) shares spiked nearly 10% in the after-hours session Wednesday, as the company said it would supply COVID-19 testing to hundreds of thousands of students in partnership with New York City Health and Hospitals at nearly 1,600 locations. What Happened: The California-based company will supply its RT-PCR at-home test, approved under United States Federal Drug Administration emergency use authorization, for students, as they return to … Full story available on Benzinga.com

Benzinga | September 2, 2020

Why Fulgent Genetics Stock Can Keep Soaring

Fulgent Genetics stock has gained 253% so far this year. Strong growth and a reasonable valuation suggest the rally will continue.

InvestorPlace | August 25, 2020

Read More 'FLGT' Stories Here

FLGT Price Returns

1-mo -18.76%
3-mo 23.45%
6-mo 103.82%
1-year 239.56%
3-year 725.63%
5-year N/A
YTD 152.17%
2019 306.94%
2018 -27.63%
2017 -62.14%
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7027 seconds.